Abstract
Hypertension is a complex, multifactorial disorder which is an important cause of morbidity and mortality in the modern world. The study of hypertension in the context of the metabolic syndrome has yielded some important insights into the etiology of the condition. With the recent controversy surrounding the existence of the metabolic syndrome and the clear need for further research, we have undertaken a four part review of the literature in this field to provide a comprehensive overview of experimental and clinical research as it currently stands. In Part One, we review the history of hypertension and the metabolic syndrome, discuss the role of the metabolic syndrome as a concept and a diagnosis, and provide an introduction to insulin resistance and hyperinsulinemia. We also provide a broad overview of the range of animal models which are used to study these conditions.
Keywords: Metabolic syndrome, hypertension, obesity, insulin resistance, epidemiology, history, definition of metabolic syndrome, hyperinsulinemia, insulin sensitivity, Homeostasis Model Assessment
Current Vascular Pharmacology
Title: The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models
Volume: 4 Issue: 4
Keywords: Metabolic syndrome, hypertension, obesity, insulin resistance, epidemiology, history, definition of metabolic syndrome, hyperinsulinemia, insulin sensitivity, Homeostasis Model Assessment
Abstract: Hypertension is a complex, multifactorial disorder which is an important cause of morbidity and mortality in the modern world. The study of hypertension in the context of the metabolic syndrome has yielded some important insights into the etiology of the condition. With the recent controversy surrounding the existence of the metabolic syndrome and the clear need for further research, we have undertaken a four part review of the literature in this field to provide a comprehensive overview of experimental and clinical research as it currently stands. In Part One, we review the history of hypertension and the metabolic syndrome, discuss the role of the metabolic syndrome as a concept and a diagnosis, and provide an introduction to insulin resistance and hyperinsulinemia. We also provide a broad overview of the range of animal models which are used to study these conditions.
Export Options
About this article
Cite this article as:
The Etiology of Hypertension in the Metabolic Syndrome Part One: An Introduction to the History, the Concept and the Models, Current Vascular Pharmacology 2006; 4 (4) . https://dx.doi.org/10.2174/157016106778521616
DOI https://dx.doi.org/10.2174/157016106778521616 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Advancements in Arterial Stiffness: Novel Therapeutic Frontiers
Arterial stiffness, a hallmark of cardiovascular disease, poses significant challenges in contemporary healthcare. This thematic issue delves into the multifaceted landscape of arterial stiffness and explores cutting-edge therapeutic interventions aimed at mitigating its adverse effects. Within these pages, readers will find a comprehensive overview of the mechanisms underlying arterial stiffness, ...read more
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists
Current Pharmaceutical Design Role of Inflammation in Diabetic Nephropathy
Current Diabetes Reviews The Role of Diet in Patients with Metabolic Syndrome
Current Medicinal Chemistry Role of Renin-Angiotensin System in Vascular Endothelial Dysfunction of Pregnancy-Induced Hypertension
Current Hypertension Reviews The Use of Thiazides in Chronic Kidney Disease
Current Hypertension Reviews Separation of Bioactive Peptides by Membrane Processes: Technologies and Devices
Recent Patents on Biotechnology Cellular and Physiological Effects of Soy Flavonoids
Mini-Reviews in Medicinal Chemistry Extracellular Proteases as Targets for Drug Development
Current Protein & Peptide Science National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimers Disease (CATIE-AD): Baseline Characteristics
Current Alzheimer Research New Insights on the Possible Role of Mast Cells in Aspirin-Induced Asthma
Current Molecular Pharmacology Protein and Peptide Biopharmaceuticals: An Overview
Protein & Peptide Letters Reviewing the Cardiovascular Complications of HIV Infection After the Introduction of Highly Active Antiretroviral Therapy
Current Drug Targets - Cardiovascular & Hematological Disorders Pulmonary Vasodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery
Current Vascular Pharmacology The Effects of Obesity-Related Peptides on the Vasculature
Current Vascular Pharmacology Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
Current Medicinal Chemistry Role of Renin-Angiotensin System in Inflammation, Immunity and Aging
Current Pharmaceutical Design State of the Heart: CMR in Coronary Artery Disease
Current Medical Imaging Pharmacogenomics: Integration into Drug Discovery and Development
Current Topics in Medicinal Chemistry Evolution of Global and Local Grey Matter Atrophy on Serial MRI Scans During the Progression from MCI to AD
Current Alzheimer Research Editorial [Hot topic: The Challenge of Prescribing Drugs in Older People (Guest Editors: Fabrizia Lattanzio and Andrea Corsonello)]
Current Drug Metabolism